Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 17 of 38 for:    fetal alcohol children

Nutritional Risk Factors for FASD in Ukraine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03782935
Recruitment Status : Completed
First Posted : December 20, 2018
Last Update Posted : December 20, 2018
Sponsor:
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Omni-Net Ukraine
Information provided by (Responsible Party):
Christina Chambers, University of California, San Diego

Brief Summary:
Interventional study randomizing pregnant women at two sites in Ukraine who have or have not already consumed moderate to heavy levels of alcohol in pregnancy to receiving a standard prenatal vitamin supplement with or without additional choline supplement or standard of care (recommendation to take vitamin supplements) through the remainder of pregnancy, and to compare neurobehavioral performance of the offspring on the Bayley Scales of Infant Development at 12 months of age between groups. The overall sample size target was 300 alcohol exposed and 300 low or unexposed across both sites.

Condition or disease Intervention/treatment Phase
Fetal Alcohol Spectrum Disorders Dietary Supplement: Prenatal multivitamin mineral supplement Not Applicable

Detailed Description:

Pregnant women coming in for routine prenatal diagnostic testing or prenatal care at two sites in Ukraine, Rivne Diagnostic Center or Khmelnytsky Regional Perinatal Center, were screened for alcohol consumption during pregnancy. Those who met the criteria of consuming 4-5 drinks per occasion on 3-4 occasions in either the month around conception or the most recent month of pregnancy were eligible for recruitment into the alcohol exposed group, and the next available woman who consumed no more than 2 drinks on any occasion in the month around conception or the most recent month of pregnancy was eligible for recruitment into the alcohol low or no exposure group. Within alcohol group and within site, women were randomized on a 1:1 basis to receiving a study-provided prenatal vitamin (TheraVit) manufactured in the U.S. and registered in Ukraine as an over-the-counter product, or to receiving standard of care which is obstetric advice to take prenatal vitamins on their own. Within the group randomized to receiving the prenatal vitamins, women were further randomized on a 1:1 basis to receiving an additional 750 mg. of supplemental choline manufactured in the U.S., and registered in Ukraine as an over-the-counter product.

Women in both cohorts were followed until delivery and those with live born children were followed until the child reached one year of age. The primary endpoint for the intervention was performance on the mental developmental index (MDI) and the psychomotor developmental index (PDI) components of the Bayley Scales of Infant Development II. The Bayley tests were administered at approximately 12 months adjusted chronological age by trained psychologists in Ukraine.

The primary comparison for the study was within the alcohol-exposed group, comparing mean Bayley scores on MDI and separately on PDI between those randomized to receiving the study prenatal vitamin and those randomized to standard of care.

Secondary comparisons for the study examined

  1. the mean MDI and PDI scores on the Bayley within the alcohol-exposed group in those randomized to receiving the prenatal vitamin plus choline vs. those who received the prenatal vitamin alone
  2. the mean MDI and PDI scores on the Bayley within the low or unexposed group in those who received the prenatal vitamin vs. those who did not
  3. the mean MDI and PDI scores on the Bayley within the low or unexposed group in those who received the prenatal vitamin plus choline vs. those who received the prenatal vitamin alone
  4. adjusted comparisons for all of the above taking into account participants who were taking vitamins on their own at the time of enrollment, and/or who were taking vitamins on their own if assigned to the standard of care group.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 600 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Pregnant women assigned to 1) over-the-counter approved prenatal multivitamin mineral supplement alone provided by the study at time of enrollment, 2)over-the-counter approved prenatal multivitamin mineral supplement with additional over-the-counter approved 750 mg choline supplement provided by the study at the time of enrollment, or 3) standard of care which is recommendation to take over-the-counter prenatal multivitamin mineral supplements
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Early Identification of Affected Children and Nutritional Risk Factors for FASD in Ukraine
Study Start Date : June 2006
Actual Primary Completion Date : June 2013
Actual Study Completion Date : June 2013


Arm Intervention/treatment
Experimental: prenatal multivitamin mineral supplement
received prenatal multivitamin mineral supplement at time of enrollment TheraVit multivitamin/mineral prenatal supplement with instructions to take 1 per day through the remainder of pregnancy
Dietary Supplement: Prenatal multivitamin mineral supplement
prenatal vitamin/mineral supplement with or without choline supplement
Other Name: Prenatal multivitamin mineral supplement plus choline supplement

Experimental: prenatal multivitamin mineral supplement plus choline
received prenatal multivitamin mineral supplement plus additional choline supplemental vitamin TheraVit multivitamin mineral supplement plus 750 mg. choline with instructions to take1 multivitamin mineral supplement and 750 mg. per day of choline through the remainder of pregnancy
Dietary Supplement: Prenatal multivitamin mineral supplement
prenatal vitamin/mineral supplement with or without choline supplement
Other Name: Prenatal multivitamin mineral supplement plus choline supplement

No Intervention: Comparison
Advised to follow obstetrics standard of care which is to take a prenatal vitamin/mineral supplement



Primary Outcome Measures :
  1. Bayley Scales of Infant Development II Mental Developmental Index [ Time Frame: approximately 12 months of age adjusted for preterm delivery ]
    Scaled score range 50 to 150 with higher scores indicating better performance

  2. Bayley Scales of Infant Development III Psychomotor Developmental Index [ Time Frame: approximately 12 months of age adjusted for preterm delivery ]
    Scaled score range 50 to 150 with higher scores indicating better performance



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • currently pregnant
  • reported alcohol consumption 4-5 drinks per occasion on 3-4 occasions in the month around conception or the most recent month of pregnancy, or
  • no more than 2 drinks per occasion in either the month around conception or the most recent month of pregnancy

Exclusion Criteria:

  • unable to provide consent
  • unable to provide information about alcohol consumption

Layout table for additonal information
Responsible Party: Christina Chambers, Professor of Pediatrics, University of California, San Diego
ClinicalTrials.gov Identifier: NCT03782935     History of Changes
Other Study ID Numbers: 080035
First Posted: December 20, 2018    Key Record Dates
Last Update Posted: December 20, 2018
Last Verified: December 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: This study is part of a collaborative initiative on Fetal Alcohol Spectrum Disorders and de-identified data is available to share with other researchers on a specified timetable with appropriate application for use.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Time Frame: 2020 and indefinitely
Access Criteria: Application to Collaborative Initiative on Fetal Alcohol Spectrum Disorders data oversight group at CIFASD.org
URL: http://cifasd.org
Keywords provided by Christina Chambers, University of California, San Diego:
alcohol
pregnancy
infant
Additional relevant MeSH terms:
Layout table for MeSH terms
Fetal Alcohol Spectrum Disorders
Fetal Diseases
Alcohol-Induced Disorders
Alcohol-Related Disorders
Pregnancy Complications
Substance-Related Disorders
Chemically-Induced Disorders
Vitamins
Choline
Micronutrients
Nutrients
Growth Substances
Physiological Effects of Drugs
Lipotropic Agents
Hypolipidemic Agents
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Gastrointestinal Agents
Lipid Regulating Agents
Nootropic Agents